Pharmaceutical promotion: don't throw the baby out with the bathwater.
Spending on prescription drugs and promotion by the pharmaceutical industry grew substantially during the past ten years. Does the greater exposure offered by promotion fill a needed educational gap, or does it merely promote inappropriate use? This paper uses two recent studies to explore this question, presenting a framework in which the impact of promotion depends upon the level of evidence and consensus on drug use.
Dubois
Robert W
RW
Zynx Health Inc., Beverly Hills, California, USA.
D032921:Consensus; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D011307:Drug Prescriptions / Q000191:economics / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000706:statistics & numerical data*; D019538:Health Care Surveys; D006300:Health Services Misuse; D006801:Humans; D040541:Marketing / Q000639:trends*; D010358:Patient Participation; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D014481:United States